India New Issue-Eris Lifesciences to issue 3-year bonds, bankers say
MUMBAI, May 31 (Reuters) - India's Eris Lifesciences ERIS.NS plans to raise 12.50
billion rupees ($150.1 million) through a sale of bonds maturing in three years, three bankers
said on Friday.
The company has invited coupon and commitment bids from bankers and investors on Thursday,
they said.
Here is the list of deals reported so far on May 31:
Issuer Tenure Coupon (in %) Issue size (in Bidding Rating
bln rupees)* date
Eris 3 years To be decided 12.50 June 6 AA- (India
Lifesciences Ratings)
5 years 8.18 22.75 May 30 AAA (Crisil,
M&M Financial India Ratings)
*Size includes base plus greenshoe for some issues
($1 = 83.2670 Indian rupees)
(Reporting by Dharamraj Dhutia and Bhakti Tambe; Editing by Varun H K)
((Dharamraj.dhutia@tr.com))
Recent news on Eris Lifesciences
See all newsIndia's Eris Lifesciences gains on strong quarterly results
Brief: Eris Lifesciences Sept-Quarter Consol Net Profit 1.84 Billion Rupees
Brief: Eris Lifesciences Says Krishnakumar Vaidyanathan Resigns As Executive Director & COO
Brief: Eris Lifesciences Ltd Says June-Quarter Consol Net Profit 1.42 Billion Rupees
Brief: Eris Lifesciences March-Quarter Consol Net Profit 2.82 Billion Rupees